Humana Inc. (NYSE:HUM) Receives $315.86 Average PT from Brokerages

Humana Inc. (NYSE:HUM - Get Free Report) has received an average recommendation of "Hold" from the twenty-five research firms that are currently covering the company, MarketBeat.com reports. Nineteen equities research analysts have rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average twelve-month target price among analysts that have issued ratings on the stock in the last year is $315.86.

A number of equities research analysts recently commented on HUM shares. Piper Sandler downgraded Humana from an "overweight" rating to a "neutral" rating and decreased their target price for the stock from $392.00 to $274.00 in a report on Thursday, October 3rd. Wells Fargo & Company cut their price objective on shares of Humana from $387.00 to $290.00 and set an "overweight" rating on the stock in a research note on Monday, November 4th. Sanford C. Bernstein upgraded shares of Humana from a "market perform" rating to an "outperform" rating and set a $308.00 target price for the company in a research report on Tuesday, October 8th. JPMorgan Chase & Co. increased their price target on Humana from $332.00 to $396.00 and gave the stock a "neutral" rating in a research report on Wednesday, August 21st. Finally, Deutsche Bank Aktiengesellschaft lowered their target price on Humana from $349.00 to $250.00 and set a "hold" rating on the stock in a research note on Thursday, October 3rd.

Hedge Funds Weigh In On Humana

Hedge funds and other institutional investors have recently modified their holdings of the business. Sequoia Financial Advisors LLC lifted its stake in Humana by 44.0% in the 2nd quarter. Sequoia Financial Advisors LLC now owns 2,334 shares of the insurance provider's stock worth $872,000 after purchasing an additional 713 shares in the last quarter. Wealth Enhancement Advisory Services LLC increased its stake in shares of Humana by 9.9% in the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 8,713 shares of the insurance provider's stock worth $3,256,000 after acquiring an additional 787 shares during the last quarter. Envestnet Portfolio Solutions Inc. increased its stake in shares of Humana by 14.4% in the 2nd quarter. Envestnet Portfolio Solutions Inc. now owns 5,490 shares of the insurance provider's stock worth $2,051,000 after acquiring an additional 689 shares during the last quarter. AdvisorNet Financial Inc boosted its position in shares of Humana by 18.6% during the 2nd quarter. AdvisorNet Financial Inc now owns 287 shares of the insurance provider's stock valued at $107,000 after acquiring an additional 45 shares during the last quarter. Finally, 180 Wealth Advisors LLC boosted its position in shares of Humana by 13.0% during the 2nd quarter. 180 Wealth Advisors LLC now owns 1,156 shares of the insurance provider's stock valued at $439,000 after acquiring an additional 133 shares during the last quarter. 92.38% of the stock is owned by hedge funds and other institutional investors.

Humana Stock Down 2.7 %

Shares of HUM traded down $7.62 during mid-day trading on Wednesday, hitting $278.20. 1,756,966 shares of the company traded hands, compared to its average volume of 1,844,129. The company has a market capitalization of $33.50 billion, a PE ratio of 24.64, a price-to-earnings-growth ratio of 2.18 and a beta of 0.53. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.67. The business has a 50 day moving average of $272.20 and a 200 day moving average of $325.92. Humana has a 1-year low of $213.31 and a 1-year high of $488.89.

Humana (NYSE:HUM - Get Free Report) last issued its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $3.48 by $0.68. The business had revenue of $29.30 billion for the quarter, compared to analyst estimates of $28.66 billion. Humana had a net margin of 1.18% and a return on equity of 13.20%. Equities research analysts anticipate that Humana will post 16.14 EPS for the current year.

Humana Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be issued a $0.885 dividend. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $3.54 dividend on an annualized basis and a yield of 1.27%. Humana's payout ratio is currently 31.36%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.